Vespula Therapeutics Ltd
15191029
Some Concerns
- Negative net worth (-10)
- Current liabilities exceed current assets (-10)
Details
Compliance
Last accounts
31/10/2025
unaudited abridged
Next accounts due
31/07/2027
Confirmation statement
Last: 04/10/2025
Due 18/10/2026
Industry
Officers
Former
director · Resigned 27/01/2025
Persons with Significant Control
4bio Ventures Ii L.P. Acting By Its General Partner 4bio Ventures Ii Gp Limited
86-90, Paul Street, London, EC2A 4NE
Reg: 11645094 · Uk Register Of Companies · Private Company Limited By Shares
Notified 05/10/2023
Change History
Active
Private Limited Company
86-90 PAUL STREET
LONDON
CompanyRankvs 2124+ SIC 72110 peers42
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/10/2025
Net Worth
-£614k
Balance sheet strength
Cash
£138k
Cash in the bank
Net Current Assets
£105k
Working capital
Current Assets
£138k
Current Liabilities
£34k
Fixed Assets
£416k
Debtors
£0
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 4.11 | -£60k |
| 2024 | 5.62 | — |
Derived from filed accounts. Not audited figures.